Literature DB >> 26238031

Kidney cancer: AXL RTK--a therapeutic target in RCC?

Louise Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26238031     DOI： 10.1038/nrurol.2015.196

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma.

Authors:  H Yu; R Liu; B Ma; X Li; H-Y Yen; Y Zhou; V Krasnoperov; Z Xia; X Zhang; A M Bove; M Buscarini; D Parekh; I S Gill; Q Liao; M Tretiakova; D Quinn; J Zhao; P S Gill
Journal:  Br J Cancer       Date:  2015-07-16       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.